Media coverage
1
Media coverage
Title A Study to Evaluate the Safety and Efficacy of Bimekizumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17 or IL-23 Therapies Media name/outlet TB & Outbreaks Daily News Country/Territory United States Date 15/04/24 Persons Mark Lebwohl